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Abstract 
The TOMM40-APOE locus has been associated with a number of age-related 
phenotypes in humans including non-pathological cognitive ageing, late-onset Alzheimer’s 
disease and longevity. Here we investigate the influence of the TOMM40 intron 6 poly-T 
variant (rs10524523) on TOMM40 gene expression and cognitive abilities and decline in a 
cohort of 1613 community dwelling elderly volunteers who had been followed for changes in 
cognitive functioning over a period of 14 years (range 12-18 years). We showed that the 
shorter length poly-T variants were found to act as a repressor of luciferase gene expression 
in reporter gene constructs. Expression was reduced to approximately half of that observed 
for the very long variant. We further observed that the shorter poly-T variant was significantly 
associated with reduced vocabulary ability and a slower rate of vocabulary decline with age 
compared to the very long poly-T variants. No significant associations were observed for 
memory, fluid intelligence or processing speed, although the direction of effect, where the 
short variant was correlated with reduced ability and slower rate of decline was observed for 
all tests. Our results indicate that the poly-T variant has the ability to interact with 
transcription machinery and differentially modulate reporter gene expression and influence 
vocabulary ability and decline with age.  
  
 
 
1. Introduction  
As human life expectancy is increasing, age-related cognitive impairment is 
becoming a substantial problem due to its high social (Tannenbaum et al., 2005) and 
economic (Comas-Herrera et al., 2007) burdens. Consequently the identification of genetic 
risk factors for cognitive ageing is becoming a high priority research area that aims to 
prevent or slow down the progression of cognitive decline in later life. Cognitive ageing can 
be non-pathological (also known as normal ageing) (Davies et al., 2014) or caused by 
pathological diseases such as Alzheimer’s disease (AD) (Bakulski et al., 2012). AD, 
cognitive ability and cognitive decline are highly heritable with the strongest and most 
consistent associations being reported within the Translocase of Outer Mitochondrial 
Membrane 40 Homolog and Apolipoprotein E (TOMM40-APOE) locus which occupies an 
18kb region on chromosome 19. Twin and adoption studies suggest that additive genetic 
effects contribute over half of the adult population variance in intelligence (Deary et al., 
2010) with between 0.40 to 0.51 of this variation being accounted for by common SNP 
markers (Davies et al., 2011). A lifetime (age 11 to old age) study of cognitive change 
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estimated a narrow-sense heritability of 0.24 with the genetic correlation between 
intelligence at age 11 and old age to be 0.62 (Davies et al., 2014). 
TOMM40 codes for the central component of the translocase of the outer 
mitochondrial membrane (TOM) which is a multi-subunit complex made up of six TOM 
proteins (Humphries et al., 2005). TOM is a channel forming protein involved in the transport 
and sorting of proteins across the mitochondrial membrane. TOMM40 has been reported to 
be involved in the predisposition to AD and non-pathological cognitive decline possibly 
through a theory known as the “mitochondrial cascade hypothesis” which proposes a genetic 
contribution towards mitochondrial durability and function (Swerdlow et al., 2009). SNPs 
within the TOMM40 gene have been associated with plaque and vascular amyloid deposition 
(Valant et al., 2012). Several TOMM40 SNPs have been associated with non-pathological 
cognitive ageing (Davies et al., 2014; Greenbaum et al., 2014) but none of these have yet 
been shown to be functional and the possibility remains that they may be in linkage 
disequilibrium with another TOMM40-APOE variant. The TOMM40 gene is 2104 base pairs 
from APOE and they share the same linkage disequilibrium block (Lyall et al., 2013) making 
it difficult to identify discreet predisposing functional regions. 
Retrotransposons have been less thoroughly studied in disease states than SNPs 
but have recently been associated with several conditions including Rett syndrome, Ataxia 
telangiectasia and schizophrenia (Erwin et al., 2014; Coufal et al., 2011). Retrotransposons, 
also known as mobile DNA elements, encompass up to 45% of the human genome. Their 
mobilization occurs via ‘copy and paste’ mechanisms that require the presence of an RNA 
intermediate which is subjected to reverse transcription and integration into DNA at a locus 
different than the original sequence (Raiz et al., 2012). They are mobilized in the germline 
genome during early stages of embryonic development and in somatic cell types of the 
brain, leading to both de-novo germline and somatic mutations (Erwin et al., 2014; Damert et 
al., 2009). Among them, non-long terminal repeat elements such as long interspersed 
nuclear elements (LINEs), short interspersed nuclear elements (SINEs) and SINE-VNTR-
Alus (SVAs) constitute approximately 34% of the genome (Bekris et al., 2012). SINEs, such 
as Alus are very abundant between exons 6 and 7 of TOMM40. Particularly interesting is a 
block of six adjacent SINEs: AluSx, AluYc3, AluJb, AluJo, another AluJb and FLAM_A. 
FLAM_A encompasses the poly-T variant rs10524523, (henceforth ‘523’). This block also 
constitutes a human block of insertions with only limited homology seen in other primates but 
not observed in other non-primate species. ‘523’ has been analysed according to its length 
and is reported as having three variants that are short (S) <20 T residues, long (L) 20-30 and 
very long (VL) ≥30Ts (Roses et al., 2010). Roses and colleagues have shown that the 
TOMM40 L variant is in strong LD with APOEε4 and that the S and VL variants are in strong 
LD with the APOEε3. The longer TOMM40 variants have been linked to a higher risk of 
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developing late onset Alzheimer’s disease (LOAD) and an earlier age of the disease onset 
compared to the short variant in APOEε3 patients (Roses et al., 2010; Lutz et al., 2010). 
However, other studies have either not observed this association or reported that the VL 
variant was associated with lower risk of AD (Jun et al., 2012; Cruchaga et al., 2011). 
Another study also reported that the VL variant was associated with lower risk of AD and that 
the L variant was associated with increased risk (Maruszak et al., 2012). This same group 
also found that the L variant significantly reduced the chance of living to 100 years of age. 
The ‘523’ S variant has also been associated with improved memory and executive function 
in several studies (Greenbaum et al., 2014; Caselli et al., 2012; Hayden et al., 2012; 
Johnson et al., 2011). 
The location of these candidate genetic risk factors within non-coding regions of the 
TOMM40-APOE locus suggest the possible involvement of transcriptional and post-
transcriptional regulation. Our group has previously demonstrated that SVAs can serve as 
transcriptional regulators in a classical reporter gene assay in vitro and in vivo (Savage et 
al., 2013; Savage et al., 2014). Here we hypothesise that ‘523’ variants may regulate the 
expression of TOMM40 and have an influence on cognitive abilities and their decline (over a 
mean period of 14 years) with age in a cohort of 1613 non-demented community-dwelling 
older volunteers. 
 
 
2. Material and Methods   
2.1 Cohort 
The University of Manchester Longitudinal Studies of Cognition in Normal Healthy Old Age 
documented longitudinal trajectories in cognitive function in a large sample of older adults in 
the North of England, UK; the Manchester and Newcastle Longitudinal Studies of Cognitive 
Ageing Cohorts (Rabbitt et al., 2004). Recruitment took place in Newcastle and Greater 
Manchester between 1983 and 1992. At the start of the study, 6063 volunteers were 
available, (1825 men, 4238 women), with a median age of 65 years (range 44 to 93 years). 
Over the period 1983 to 2003, two alternating batteries of cognitive tasks applied biennially 
were designed to measure fluid and crystallized aspects of intelligence. The studies have 
run for over 30 years and have collected a rich archive of demographic (including date and 
location of birth), lifestyle, health, cognitive and emotional health data. This programme of 
work continues at Manchester University and it will follow subjects to death. DNA was 
available on 1613 volunteers. Ethical approval for all projects was obtained from University 
of Manchester. 
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2.2 Cognitive measures 
Principle components analysis has been used to derive variables for memory, vocabulary 
ability, fluid intelligence (novel problem solving) and processing speed for the Manchester 
and Newcastle cohorts. The vocabulary ability (crystallized intelligence) factor was 
generated using tests that comprised the Mill Hill and Wais vocabulary tests (Rabbitt et al., 
2004; Raven, 1965). Cognitive tests used for fluid factors were the two parts of the Alice 
Heim test 4 and the four subtests of the Culture Fair Test (Heim, 1970; Cattell, 1949). Speed 
factors were derived from the Alphabet Coding Task and the Random Letters test (Rabbitt et 
al., 2004; Savage, 1984). Factors for memory were generated from free recall, propositions 
and spatial memory tests (Rabbitt et al., 2004). 
In all cases men and women were examined and scores standardized separately. 
Longitudinal growth curve models were estimated that took the 0 point on the age scale as 
age 70, and measured variation about that in units of 10 years. Data were available for up to 
four occasions (collected at roughly 5 year intervals) of measurement that spanned an 
average of 14 years (range 12–18 years) for all volunteers. The fixed part of the models that 
described the overall pattern of change in the construct for the sample as a whole included 
linear and quadratic age terms. In addition, to account for possible artifactual improvement 
due to practice effects (a single step function), each test score was allowed to increment 
between the first and subsequent occasions in which each particular test was taken. 
Individual differences were accounted for by allowing subject-specific random effects for the 
intercept, describing the within-sample variation in performance at age 70, and for a linear 
growth term, describing the individual differences in the trend of cognitive decline over the 
period of follow-up. The random effects were assumed to be bivariate normally distributed 
and the models estimated in gllamm by maximum likelihood using adaptive quadrature 
(www.gllamm.org). Incomplete data observations were included under an assumption that 
the missing scores were missing at random, allowing attrition to be selective with respect to 
age, sex, and observed test scores. Subject-specific intercepts and linear trends were 
estimated using empirical Bayes’ methods. The above fully describes the model in the 
circumstance where a single repeated cognitive test was available. Different tests were 
allowed different means, scales and error variances but the tests were assumed to reflect a 
single underlying construct with a common trend.  
 
 
2.3 ‘523’ Poly T/APOE genotyping and analysis 
A polymorphic poly-T variant, rs10524523 (‘523’), in the TOMM40 gene was genotyped by 
the Roses laboratory using a method described previously (Linnertz et al., 2012). Briefly, 
TOMM40 ‘523’ poly-T genotypes were determined based on length variation. The ‘523’ 
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region of each genomic DNA sample was PCR-amplified using a fluorescently labeled 
primer. Genotypes were determined on an ABI 3730 DNA Analyzer using GeneMapper, 
version 4.0 software (Applied Biosystems, Foster City, CA) for allelic size assessment. The 
‘523’ allele was assigned according to the length of the PCR product. The convention 
established by Roses et al for determining alleles was used: Short (S), <20 T residues; Long 
(L) - 20-29; Very Long (VL) ≥30 (Roses et al., 2010). Six genotypes were generated 
according to the length/combination of the alleles which consisted of: 1.S/S; 2. S/L; 3. S/VL; 
4. L/L; 5. L/VL and 6. VL/VL. APOE genotyping was performed using Sequenom technology 
(Sequenom®, San Diego). This method has been described previously (Ghebranious et al., 
2005). The IplexTM assay was followed according to manufacturer’s instructions 
(http://www.sequenom.com) using 30ng of DNA. Linear regression analysis of genotype and 
cognitive phenotypes were performed in Stata (StataCorp. Stata Statistical Software: 
Release 13. College Station, TX: StataCorp LP). Our sample size of 1613 individuals has 
89% power to detect a genetic effect size of 0.01 or greater assuming an additive model, 
stringent significance of 0.005 (two-tailed) and minor allele frequency of 0.13. The minor 
allele frequencies of the ‘523’ alleles were S, 0.42; L, 0.13; VL, 0.45. 
 
 
2.4 Bioinformatics 
The genetic variation found between exons 6 and 7 of the TOMM40 gene as well as the 
local environment and conservation profiles were analysed using the UCSC (http://genome-
euro.ucsc.edu/index.html) and ECR (http://ecrbrowser.dcode.org/) browsers. The SINEs 
block (chr19:45,401,766-45,403,217 on Hg19 release) within the intron 6 region of TOMM40 
contains 6 Alu domains which all contain T-rich areas (Figure 1). The most 3’ of the Alu 
elements is a FLAM_A which contains the ‘523’ variants. All of the Alu domains contain long 
poly-T stretches or T-rich regions and are located on the negative strand, with the exception 
of AluYc3, which is found on the positive strand. The region also encompasses two short T-
rich regions, classified as simple repeats, which are composed of 25 and 11 bp and are 
located on the positive strand.  
 
 
2.5 Cloning and measuring luciferase expression directed by ‘523’ reporter gene 
constructs 
The TOMM40 fragment containing the SINE block was amplified from human genomic DNA 
(Promega) using Touchdown (TD)-PCR with Phusion Polymerase (NEB). The TD-PCR 
products were cloned into pGL3 promoter (pGL3p) and pGL3 control (pGL3c) vectors 
(Promega) and termed TOMM40/pGL3p and TOMM40/pGL3c respectively. This fragment 
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contained a 35T variant of rs10524523. Further truncated clones of the SINE were 
generated by PCR to address more specifically the Flam_A element containing rs10524523 
(‘523’). Three FLAM_A ‘523’ variants generated; FLAM_A17T, FLAM_A34T and 
FLAM_A41T. Two of these FLAM_A 17T; FLAM_A 41T possessed identical sequence with 
the exception of the ‘523’ region which reflected the length of the polymorphic T-stretch 
encompassing the SNP rs10524523 and comprised either a run of 17 or 41 Ts. Flam_A34T, 
in contrast, consists of 34 Ts in the ‘523’ region; it is truncated at the 5’ end relative to 
FLAM_A17T & 41T as outlined in Figure 1.  
 
 
[FIGURE 1 HERE] 
 
Figure 1: Reporter Gene Constructs spanning Hg19 chr19:45,401,688 – 45,403,254 showing 
polymorphism rs10524523 and the T-rich region. 
 
 
 
The human neuroblastoma cell line SK-N-AS (ECACC# 94092302) was maintained in 
Dulbecco’s Modified Eagle medium with glucose (4500 mg/L) (Sigma) supplemented with 
10% (v/v) foetal bovine serum, 1% (v/v) MEM non-essential amino acid solution and 
100U/ml Penicillin, 100µg/ml Streptomycin. Prior to transfection, cells were plated out in 24-
well plates at an approximate density of 6x104 cells per well. Transfection was performed 
approximately 24 hours post-plating with 1µg of the appropriate reporter gene construct and 
10ng of internal control construct TK renilla using TurboFect (Thermo Scientific) following 
manufacturer’s instructions and using serum-free media for transfection. 48 hours post-
transfection cells were lysed and the Dual Luciferase Reporter Assay (Promega) was 
performed. Luminescence was measured using a Glomax 96 Microplate Luminometer 
(Promega). We performed duplicate experiments each with four repeats for each construct. 
Statistical one-way ANOVA with Bonferroni correction for the three FLAM constructs 
and normal t-test for SINE block in both pGL3p and pGL3c were performed to determine the 
significance of the fold change of the reporter gene constructs over the pGL3p or pGL3c 
alone. Significance was scored as follows: *P<0.05, **P<0.01, ***P<0.001. Details regarding 
the cloning and expression methods can be obtained on request. 
 
3. Results 
3.1 Functional activity of the intron 6 SINE block in reporter gene analysis 
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The generated reporter gene constructs were assessed for their ability to direct 
reporter gene expression (luciferase) driven by a heterologous SV40 promoter in human 
neuroblastoma cell line SK-N-AS. As shown in Figure 2 A, the intron SINE containing the 
34T variant significantly lowered the reporter gene expression when compared to the 
minimal promoter (pGL3p) alone (p<0.001 and p<0.01). In order to confirm the repression 
observed in the pGL3p vector, the fragment was also analyzed when inserted into pGL3c 
vector, (which exhibits 7-8 fold higher intrinsic activity than pGL3p). The results for pGL3c 
were consistent with the results observed for pGL3p and showed that the 17T SINE block 
significantly reduced the expression of luciferase when compared with the pGL3c vector 
alone (p<0.01 and p<0.001) (Figure 2 B). 
 
 
 
 
[FIGURE 2 HERE] 
 
Figure 2: SINE block showed the ability to down-regulate expression in a reporter gene 
construct. A) The average fold activity of the SINEs block of TOMM40 over the minimal SV40 
promoter alone (pGL3p). B) The average fold activity of the SINEs block of TOMM40, containing 34T 
stretch, over the pGL3 control vector which in addition to SV40 promoter also contains an SV40 
enhancer. T-tests were performed to measure the significance of the average fold and were scored as 
follows: *P<0.05, **P<0.01, ***P<0.001 
 
 
3.2 Functional activity of the FLAM_A ‘523’ variants in reporter gene analysis 
To address if a functional difference was supported by the high and low T variants we 
compared FLAM_A17T and 41T which only vary in the number of Ts in each construct 
(Figure 2). The FLAM_A17T showed the greatest ability to alter the reporter gene activity 
and significantly repressed the levels of reporter gene expression, when compared to the 
minimal promoter alone (p<0.001). In contrast, FLAM_A 41T had no effect on transcription. 
Significant reduction in luciferase activity was also observed for FLAM_A34T (p value, <0.01 
and <0.05), however, the repression was not as great as that observed for FLAM_A 17T. 
Our results would be consistent with a model in which the shorter the ‘523’ variant i.e. the 
lower the number of thymine residues, within FLAM_A region, the greater its ability to 
modulate transcription.   
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[FIGURE 3 HERE] 
Figure 3: Distinct polymorphic T runs showed the ability to affect expression in a reporter 
gene construct. The average fold activity of the three variants over the minimal SV40 promoter alone 
(pGL3p). Significant difference in fold activity between the fragments: One-way ANOVA with 
Bonferroni correction was performed and was scored as follows *P<0.05, **P<0.01, ***P<0.001 
 
 
3.3 Regression analysis of ‘523’ and memory ability and decline with age 
‘523’ genotype frequencies were: S/S (n=261, 16.2%); S/L (n=213, 13.2%); S/VL 
(n=626, 38.8%); L/L (n=27, 1.7%); L/VL (n=162, 10.0%) and VL/VL (n=324, 20.1%). These 
frequencies were similar to those reported in another UK cohort (Lyall et al., 2013). 
Regression analysis suggested that vocabulary ability (a measure of crystallized intelligence) 
was the most strongly influenced by ‘523’ with the short variant associated with a lower 
ability. This was most evident (p-value, 0.007) when volunteers who were homozygous for 
the short allele (n=261) were compared against those homozygous for the very long allele 
(n=324) (mean residual scores for vocabulary ability at initial testing point S/S, -0.130; 
VL/VL, 0.090). Significance was also observed for vocabulary ability at initial testing point (p-
value, 0.05) when all volunteers underwent regression analysis in the genotype order S/S, 
S/L, S/VL, L/L, L/VL, VL/VL. It was also found that the rate of vocabulary decline was faster 
for those who were homozygous for the very long allele compared to those who were 
homozygous for the short allele, although the significance was marginal (p-value, 0.05). No 
significant associations were observed for memory, fluid intelligence or processing speed, 
although the direction of effect, where the S variant was correlated with reduced ability and 
slower rate of decline, was observed for all tests.  
To determine if the association with the TOMM40 short allele and vocabulary ability 
was being influenced by APOE we analysed APOE (ε2, ε3 and ε4) genotypes in 1539 
participants against the vocabulary measure. The allele frequencies were 8.3% (ε2); 78.1% 
(ε3) and 13.6% (ε4), which is similar to those reported in other studies (Corbo RM and 
Scacchi R, 1999). Analysis was performed on three genotype groups (volunteers with no ε4, 
one ε4 and two ε4 alleles) using an additive model. No association between APOE genotype 
was observed for vocabulary ability (p-value, 0.576) or its decline over time (p-value, 0.464). 
The ‘523’ homozygous S and VL variants were also investigated in homozygous APOEε3 
volunteers but this failed to strengthen significance. 
We considered this study an attempt to replicate previous findings and therefore did 
not adjust for multiple testing.  
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4. Discussion 
We have shown that a primate specific retrotransposon domain containing the 
genetic variant ‘523’ within the TOMM40 gene can serve as a differential regulator of gene 
expression based on genotype of the T repeat and has an influence on crystallized 
intelligence and decline in non-pathological ageing. Specifically, we report that the short 
poly-T variant was associated with reduced reporter gene expression, reduced vocabulary 
ability and a slower rate of vocabulary decline in a cohort of 1613 volunteers. The 
association between the TOMM40-APOE locus and cognitive impairment have been 
amongst the most extensively reported and consistent findings in the field of complex 
genetic diseases/traits. The functional relevance of these genes in the aetiology of cognitive 
impairment adds weight to their involvement. ApoE not only serves in the transport and 
breakdown of lipoproteins but also influences amyloid-β clearance and competes with 
amyloid-β for cellular uptake via apoE receptors (Kanekiyo et al., 2014). TOMM40 encodes 
a translocase of outer mitochondrial membrane 40, a subunit of a larger TOM complex 
responsible for the translocation of newly synthesized unfolded proteins into the 
mitochondrial intermembrane space (Humphries et al., 2005). Mitochondria are essential for 
cell survival and their dysfunction has been linked to pathological and non-pathological 
cognitive ageing (Bishop et al., 2010).  
Until recently the focus of cognitive/dementia genetic research has relied heavily 
upon SNP data with little emphasis on other variant types. Here we have focused on the 
function of noncoding DNA associated with SNPs highlighted in our previous association 
studies for their ability to exert regulatory properties at the locus. Of particular interest at this 
locus are the properties of the multiple Alu elements which constitute a human specific 
domain with limited homology seen in other primates. Retrotransposon domains in 
noncoding regions of the genome can introduce novel splice sites, polyadenylation signals, 
promoters and regulatory domains that can reorganize gene expression and build new 
transcription modules (Erwin et al., 2014). The position of retrotransposons within introns 
and other local environments enhances their ability to alter local architecture and 
consequently, modulate genome regulation (Quinn et al., 2014). We have previously 
demonstrated that primate specific SVA retrotransposons in the promoter of the 
neurodegenerative candidate genes, PARK7 and FUS, similarly to our present study, are 
both polymorphic and modulate reporter gene expression (Savage et al., 2013; Savage et 
al., 2014).   
Our data (Quinn et al., 2014) indicates that the SINE domain or the FLAM_A domain 
could mechanistically modulate vocabulary ability and decline by altering TOMM40 gene 
expression perhaps in response to an additional environmental challenge. However, these 
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regions could also be hot spots for retrotransposition itself so affecting the function at the 
locus by multiple mechanisms. With the exception of early embryo development and some 
malignancies, retrotransposition is suppressed by epigenetic and post-transcriptional 
modifications in somatic cells, although their mobilization has been reported in the adult 
brain. Baillie and colleagues have detected somatic L1 retrotransposition of three active 
retrotransposon families: LINE-1, Alu and SVA, which resulted in alteration of the genetic 
landscape of the human brain (Baillie et al., 2011). Consistent with CNS mobilisation, next-
generation sequencing studies have shown that there is a bias for insertion sites of somatic 
L1 retrotransposition in neurons of schizophrenia brains and that these events could have an 
etiological role (Bundo et al., 2014). More recently dysregulated retrotransposon function has 
been observed in frontal frontotemporal lobar degeneration which the authors’ link to activity 
of the neurodegenerative risk gene TDP-43 (Li et al., 2012). Furthermore, many studies 
including our own have indicated age as a parameter affecting human cognition. This is 
consistent with the observation that in the model organism Drosophila, increased activity of 
transposable elements in the brain contribute to age-dependent loss of neuronal 
function (Li et al., 2012). 
The TOMM40 ‘523’ alleles have a commonly used categorization where they are 
divided into three groups depending on the length of the T homopolymer: T≤19 (S), Ts=20-
29 (L) and T≥30 (VL). The original study by Roses and colleagues reported that longer poly-
T length (in particular, T≥27) was associated with earlier age of AD onset and risk compared 
with individuals with shorter T-homopolymers in people of European descent (Roses et al., 
2010). This study was conducted using three independent cohorts with numbers of cases 
ranging from 34 to 83 and numbers of controls ranging from 31 to 67. In contrast a larger 
study of 1594 AD cases and 1190 controls (all European descent) found no association 
between the VL variant in homozygous APOEε3 individuals and age of AD onset but did 
report that the VL variant was associated with lower AD risk (Cruchaga et al., 2011). This 
finding was supported by an independent group who investigated the ‘523’ variant using 414 
AD cases, 173 centenarians and 305 neurologically healthy controls (Maruszak et al., 2012). 
This study also reported that the L variant was associated with increased risk of AD and a 
reduced likelihood of living to 100 years of age. Finally, a meta-analysis study of 11840 AD 
patients and 10931 controls found no association between ‘523’ variants and AD risk (Jun et 
al., 2012). The differences in results observed between the above studies may be explained 
by variation in study design which has been discussed in detail elsewhere (Roses et al., 
2013). Accuracy in assigning poly-T length, generating meaningful prognostic haplotypes 
between TOMM40 and APOE, variation caused by age-dependent risk of AD and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
differences in AD diagnosis methodology were some of the reasons highlighted by Roses 
and colleagues.   
The association between the ‘523’ variant and cognition has been a little more 
consistent than the AD reports, although the cohort sizes have been small. Johnson et al 
found that those homozygous for the VL variant (n=35) scored lower on a test of primary 
retrieval from a verbal list learning task than S homozygous individuals (n=38) (mean age of 
cohort, 55 years) (Johnson et al., 2011). Two further studies by Hayden (Hayden et al., 
2012) and Greenbaum (Greenbaum et al., 2014) (n=127, mean age 80.6 and n=331, ≥65 
years, respectively) observed that those homozygous for the S variant performed better on 
tests of memory and executive function, although in these studies the results either did not 
reach significance or were only marginally significant. A larger study of 639 cognitively 
normal individuals aged 21-97 years found that those homozygous for the VL variant had a 
flattened test-retest improvement that was only observed in those aged under 60 years 
(Caselli et al., 2012). 
Our results showed a faster rate of cognitive decline in volunteers who carried the VL 
variant which was marginally significant for vocabulary ability. In contrast to other cognitive 
studies who measured intelligence at a single time point using neurologically healthy 
participants we observed that the S variant was associated with reduced scores which 
reached significance with vocabulary ability but not memory, fluid intelligence or processing 
speed. The reasons for our observed differences may be related to population stratification 
as the Greenbaum study investigated TOMM40 in an Israeli Jewish population and the 
Johnson study did not mention their population ethnicity. The Hayden study was 
predominantly Caucasian, but their results failed to reach significance after correction for 
multiple testing. Statistical power is unlikely to be an issue in our analysis as our cohort size 
of 1613 was larger than the other studies on cognitively healthy individuals combined (89% 
power to detect a 1% genetic effect size at a stringent p-value of 0.005). The cognitive tests 
used by the different groups also varied. Hayden used tasks that measured attention, 
processing speed, memory, executive and visuospatial function whilst the Greenbaum study 
used a factor analytical approach as we did. However, neither used a test of crystallized 
intelligence and thus we cannot compare with our vocabulary result.  
TOMM40 is located 2104 base pairs from APOE with significant LD between the two 
genes (Lyall et al., 2013). This strong LD makes it difficult to determine the causative 
region(s) and therefore we further investigated the influence of both APOE ε3 and ε4 on 
cognitive ability and decline. Phylogenetic mapping analysis has shown that the APOEε4 
allele is linked to the TOMM40 L allele and APOEε3 is linked to either the S or L alleles 
(Roses et al., 2010). We observed no association between APOEε4 and vocabulary ability 
(both cross-sectional and longitudinal measures). This observation is likely because of its 
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link with the TOMM40 L allele and not with the S or LV alleles which were the strongest 
associated alleles in this study. The ‘523’ S and VL variants were also investigated in 
homozygous APOEε3 volunteers but this failed to strengthen significance. Our results 
suggest that APOE ε3 and ε4 do not play a role in vocabulary ability or its decline with age. 
 
 
 
 
5. Conclusion 
Retrotransposons have the potential to modulate gene expression via various 
mechanisms. The presence of a primate specific mobile DNA element within the TOMM40-
APOE locus and its potential regulatory nature supports the importance of this key locus in 
higher cognitive traits and consequently cognitive dysfunction. We demonstrated the ability 
of ‘523’ polymorphism to affect transcription within a luciferase reporter gene construct and 
to influence vocabulary in non-pathological elderly volunteers.  
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Highlights 
• We investigate the influence of the TOMM40 intron 6 poly-T variant (rs10524523) on 
TOMM40 gene expression and cognitive abilities and decline). 
• We showed that the shorter length poly-T variants were found to act as a repressor of 
luciferase gene expression in reporter gene constructs.  
• We further observed that the shorter poly-T variant was significantly associated with 
reduced vocabulary ability and a slower rate of vocabulary decline with age compared to the 
very long poly-T variants.  
